4JU-26823-12750
2 vaccinations
2 coded responses
18 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 355 / AL
- Registered
- 2021-09-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-03
Registered in v-safe
-
2021-09-03
Dose 1 — Pfizer-BioNTech
- 2021-09-03
- 2021-09-04
- 2021-09-06
- 2021-09-07
- 2021-09-08
- 2021-09-09
- 2021-09-10
- 2021-09-17
-
2021-09-28
Dose 2 — Pfizer-BioNTech
-
2021-09-29
Survey response — days 1–6 daily, dose 2MedDRA: Emergency care — Feeling: Poor · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Maturity ERMedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Report sent to call center — days 1–6 daily, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2021-09-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Fatigue or tirednessAdult check-in
- 2021-10-03
- 2021-10-12
- 2021-10-26
- 2021-11-02
- 2021-11-09
-
2021-12-30
Survey response — 3 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-05
- 2022-01-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-03 | Pfizer-BioNTech | No |
| 2 | 2021-09-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-29 | Unsuccessful | |
| 2021-12-30 | Unsuccessful |
Free text
Release 9 — days 1–6 daily, dose 2
Healthcare visit (other): Maturity ER
Release 10 — 3 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release